Managing Gut Autoimmunity: Advanced Microbiome Strategies for Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD) presents one of the most complex challenges in autoimmune care, requiring an integrative understanding of immune regulation, microbiome modulation, and gut barrier restoration. Clinicians must navigate a dynamic interplay between genetics, environment, stress, dysbiosis and diet to effectively reduce inflammation and achieve long-term remission.

Join Dr Brad Leech and Hannah Braye for our advanced clinical training, Managing Gut Autoimmunity: Advanced Microbiome Strategies for Inflammatory Bowel Disease, where we unpack the mechanisms that drive Crohn’s disease and ulcerative colitis and how to intervene at each stage of disease progression. Discover how to interpret microbiome and pathology data, tailor dietary interventions, and restore gut-immune balance using a clinically validated, stepwise framework.

Through evidence-based insights and practical clinical tools, this session will empower practitioners to view IBD through a microbiome-centred lens, understanding how specific microbial signatures, such as reduced butyrate-producing bacteria, increased oral species, and loss of overall diversity, drive chronic inflammation and disease activity. By identifying these distinct microbial patterns and applying targeted interventions, practitioners can move beyond symptom management to address the root microbial imbalances that sustain gut autoimmunity.

Learning Objectives
During this 1.5-hour webinar, you will learn to:

- Understand the key mechanisms driving gut autoimmunity, including microbiome dysbiosis, intestinal permeability, inflammation and immune dysregulation.
- Interpret microbiome and inflammatory markers (such as faecal calprotectin) to differentiate between functional and organic disease presentations.
- Identify common environmental, dietary, and psychosocial triggers that initiate or exacerbate IBD flares.
- Select evidence-based interventions to reduce gut inflammation and calprotectin levels.
- Develop an integrated treatment strategy that aligns gut-focused care with immune modulation and systemic inflammation management.

Note: 1 hour presentation, 30min Q&A

*Available to qualified Australian and UK healthcare practitioners only.